 | • レポートコード：GIR201102294 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、シャーガス病治療薬の世界市場を調査対象にし、シャーガス病治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AstraZeneca Plc、Kancera AB、Eisai Co Ltd、Bayer AG、Humanigen Inc、Daiichi Sankyo Co Ltd、Novartis AG、Grupo Praxis Pharmaceutical SA、GlaxoSmithKline Plc、Merck & Co Inc、Oblita Therapeutics BVBA、Sanofi ・メーカー別販売量、売上、市場シェア ・シャーガス病治療薬の地域別市場分析 ・シャーガス病治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・シャーガス病治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・シャーガス病治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・シャーガス病治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・シャーガス病治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・シャーガス病治療薬の種類別市場規模2015-2020：Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他 ・シャーガス病治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・シャーガス病治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Chagas Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Chagas Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Chagas Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chagas Disease Drug market has been segmented into
Cz-007
Cz-008
D-121
DNDI-0690
EPLBS-1246
EPLBS-967
Others
By Application, Chagas Disease Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chagas Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Chagas Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chagas Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Chagas Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Chagas Disease Drug Market Share Analysis
Chagas Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chagas Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chagas Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Chagas Disease Drug are:
AstraZeneca Plc
Kancera AB
Eisai Co Ltd
Bayer AG
Humanigen Inc
Daiichi Sankyo Co Ltd
Novartis AG
Grupo Praxis Pharmaceutical SA
GlaxoSmithKline Plc
Merck & Co Inc
Oblita Therapeutics BVBA
Sanofi
Among other players domestic and global, Chagas Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chagas Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chagas Disease Drug, with price, sales, revenue and global market share of Chagas Disease Drug in 2018 and 2019.
Chapter 3, the Chagas Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chagas Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Chagas Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Chagas Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Chagas Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chagas Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cz-007
1.2.3 Cz-008
1.2.4 D-121
1.2.5 DNDI-0690
1.2.6 EPLBS-1246
1.2.7 EPLBS-967
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Chagas Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Chagas Disease Drug Market
1.4.1 Global Chagas Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca Plc
2.1.1 AstraZeneca Plc Details
2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca Plc SWOT Analysis
2.1.4 AstraZeneca Plc Product and Services
2.1.5 AstraZeneca Plc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kancera AB
2.2.1 Kancera AB Details
2.2.2 Kancera AB Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kancera AB SWOT Analysis
2.2.4 Kancera AB Product and Services
2.2.5 Kancera AB Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eisai Co Ltd
2.3.1 Eisai Co Ltd Details
2.3.2 Eisai Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eisai Co Ltd SWOT Analysis
2.3.4 Eisai Co Ltd Product and Services
2.3.5 Eisai Co Ltd Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer AG SWOT Analysis
2.4.4 Bayer AG Product and Services
2.4.5 Bayer AG Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Humanigen Inc
2.5.1 Humanigen Inc Details
2.5.2 Humanigen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Humanigen Inc SWOT Analysis
2.5.4 Humanigen Inc Product and Services
2.5.5 Humanigen Inc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Daiichi Sankyo Co Ltd
2.6.1 Daiichi Sankyo Co Ltd Details
2.6.2 Daiichi Sankyo Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Daiichi Sankyo Co Ltd SWOT Analysis
2.6.4 Daiichi Sankyo Co Ltd Product and Services
2.6.5 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis AG SWOT Analysis
2.7.4 Novartis AG Product and Services
2.7.5 Novartis AG Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Grupo Praxis Pharmaceutical SA
2.8.1 Grupo Praxis Pharmaceutical SA Details
2.8.2 Grupo Praxis Pharmaceutical SA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Grupo Praxis Pharmaceutical SA SWOT Analysis
2.8.4 Grupo Praxis Pharmaceutical SA Product and Services
2.8.5 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline Plc
2.9.1 GlaxoSmithKline Plc Details
2.9.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline Plc SWOT Analysis
2.9.4 GlaxoSmithKline Plc Product and Services
2.9.5 GlaxoSmithKline Plc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck & Co Inc
2.10.1 Merck & Co Inc Details
2.10.2 Merck & Co Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck & Co Inc SWOT Analysis
2.10.4 Merck & Co Inc Product and Services
2.10.5 Merck & Co Inc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Oblita Therapeutics BVBA
2.11.1 Oblita Therapeutics BVBA Details
2.11.2 Oblita Therapeutics BVBA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Oblita Therapeutics BVBA SWOT Analysis
2.11.4 Oblita Therapeutics BVBA Product and Services
2.11.5 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sanofi SWOT Analysis
2.12.4 Sanofi Product and Services
2.12.5 Sanofi Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Chagas Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Chagas Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Chagas Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Chagas Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Chagas Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Chagas Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Chagas Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Chagas Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Chagas Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Chagas Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Chagas Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Chagas Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Chagas Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Chagas Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Chagas Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Chagas Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Chagas Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Chagas Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Chagas Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Chagas Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Chagas Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Chagas Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Chagas Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Chagas Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Chagas Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Chagas Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Chagas Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Chagas Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Chagas Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Chagas Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Chagas Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Chagas Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Chagas Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Chagas Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Chagas Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Chagas Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Chagas Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Chagas Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Chagas Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Chagas Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Chagas Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Chagas Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Chagas Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Chagas Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Chagas Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Chagas Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Chagas Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Chagas Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Chagas Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Chagas Disease Drug Price by Type (2015-2020)
11 Global Chagas Disease Drug Market Segment by Application
11.1 Global Chagas Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Chagas Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Chagas Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Chagas Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Chagas Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Chagas Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Chagas Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Chagas Disease Drug Market Forecast (2021-2025)
12.2.4 South America Chagas Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Chagas Disease Drug Market Forecast (2021-2025)
12.3 Chagas Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Chagas Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Chagas Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Chagas Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Chagas Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Chagas Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Chagas Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chagas Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Chagas Disease Drug Major Business
Table 9. AstraZeneca Plc Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 10. AstraZeneca Plc SWOT Analysis
Table 11. AstraZeneca Plc Chagas Disease Drug Product and Services
Table 12. AstraZeneca Plc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kancera AB Basic Information, Manufacturing Base and Competitors
Table 14. Kancera AB Chagas Disease Drug Major Business
Table 15. Kancera AB Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 16. Kancera AB SWOT Analysis
Table 17. Kancera AB Chagas Disease Drug Product and Services
Table 18. Kancera AB Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eisai Co Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Eisai Co Ltd Chagas Disease Drug Major Business
Table 21. Eisai Co Ltd Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 22. Eisai Co Ltd SWOT Analysis
Table 23. Eisai Co Ltd Chagas Disease Drug Product and Services
Table 24. Eisai Co Ltd Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 26. Bayer AG Chagas Disease Drug Major Business
Table 27. Bayer AG Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 28. Bayer AG SWOT Analysis
Table 29. Bayer AG Chagas Disease Drug Product and Services
Table 30. Bayer AG Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Humanigen Inc Basic Information, Manufacturing Base and Competitors
Table 32. Humanigen Inc Chagas Disease Drug Major Business
Table 33. Humanigen Inc Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 34. Humanigen Inc SWOT Analysis
Table 35. Humanigen Inc Chagas Disease Drug Product and Services
Table 36. Humanigen Inc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Daiichi Sankyo Co Ltd Chagas Disease Drug Major Business
Table 39. Daiichi Sankyo Co Ltd Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 40. Daiichi Sankyo Co Ltd SWOT Analysis
Table 41. Daiichi Sankyo Co Ltd Chagas Disease Drug Product and Services
Table 42. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 44. Novartis AG Chagas Disease Drug Major Business
Table 45. Novartis AG Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 46. Novartis AG SWOT Analysis
Table 47. Novartis AG Chagas Disease Drug Product and Services
Table 48. Novartis AG Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Grupo Praxis Pharmaceutical SA Basic Information, Manufacturing Base and Competitors
Table 50. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Major Business
Table 51. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 52. Grupo Praxis Pharmaceutical SA SWOT Analysis
Table 53. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product and Services
Table 54. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Plc Chagas Disease Drug Major Business
Table 57. GlaxoSmithKline Plc Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 58. GlaxoSmithKline Plc SWOT Analysis
Table 59. GlaxoSmithKline Plc Chagas Disease Drug Product and Services
Table 60. GlaxoSmithKline Plc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Merck & Co Inc Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co Inc Chagas Disease Drug Major Business
Table 63. Merck & Co Inc Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 64. Merck & Co Inc SWOT Analysis
Table 65. Merck & Co Inc Chagas Disease Drug Product and Services
Table 66. Merck & Co Inc Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Oblita Therapeutics BVBA Basic Information, Manufacturing Base and Competitors
Table 68. Oblita Therapeutics BVBA Chagas Disease Drug Major Business
Table 69. Oblita Therapeutics BVBA Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 70. Oblita Therapeutics BVBA SWOT Analysis
Table 71. Oblita Therapeutics BVBA Chagas Disease Drug Product and Services
Table 72. Oblita Therapeutics BVBA Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Chagas Disease Drug Major Business
Table 75. Sanofi Chagas Disease Drug Total Revenue (USD Million) (2018-2019)
Table 76. Sanofi SWOT Analysis
Table 77. Sanofi Chagas Disease Drug Product and Services
Table 78. Sanofi Chagas Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Chagas Disease Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 80. Global Chagas Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Chagas Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 82. Global Chagas Disease Drug Sales Market Share by Regions (2015-2020)
Table 83. Global Chagas Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Chagas Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 85. North America Chagas Disease Drug Sales Market Share by Countries (2015-2020)
Table 86. North America Chagas Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Chagas Disease Drug Revenue Market Share by Countries (2015-2020)
Table 88. Europe Chagas Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 89. Europe Chagas Disease Drug Sales Market Share by Countries (2015-2020)
Table 90. Europe Chagas Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Chagas Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 92. Asia-Pacific Chagas Disease Drug Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Chagas Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Chagas Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 95. South America Chagas Disease Drug Sales Market Share by Countries (2015-2020)
Table 96. South America Chagas Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Chagas Disease Drug Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Chagas Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 99. Middle East & Africa Chagas Disease Drug Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Chagas Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Chagas Disease Drug Revenue Market Share by Countries (2015-2020)
Table 102. Global Chagas Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 103. Global Chagas Disease Drug Sales Share by Type (2015-2020)
Table 104. Global Chagas Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 105. Global Chagas Disease Drug Revenue Share by Type (2015-2020)
Table 106. Global Chagas Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 107. Global Chagas Disease Drug Sales Share by Application (2015-2020)
Table 108. Global Chagas Disease Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 109. Global Chagas Disease Drug Market Share Forecast by Regions (2021-2025)
Table 110. Global Chagas Disease Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 111. Global Chagas Disease Drug Market Share Forecast by Type (2021-2025)
Table 112. Global Chagas Disease Drug Sales Forecast by Application (2021-2025)
Table 113. Global Chagas Disease Drug Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Chagas Disease Drug Picture
Figure 2. Global Sales Market Share of Chagas Disease Drug by Type in 2019
Figure 3. Cz-007 Picture
Figure 4. Cz-008 Picture
Figure 5. D-121 Picture
Figure 6. DNDI-0690 Picture
Figure 7. EPLBS-1246 Picture
Figure 8. EPLBS-967 Picture
Figure 9. Others Picture
Figure 10. Chagas Disease Drug Sales Market Share by Application in 2018
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Others Picture
Figure 14. Global Chagas Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Chagas Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Chagas Disease Drug Sales Market Share by Manufacturer in 2019
Figure 35. Global Chagas Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Chagas Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Chagas Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Chagas Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Chagas Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 42. Global Chagas Disease Drug Revenue Market Share by Regions in 2018
Figure 43. North America Chagas Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. Europe Chagas Disease Drug Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Chagas Disease Drug Sales and Growth Rate (2015-2020)
Figure 46. South America Chagas Disease Drug Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Chagas Disease Drug Sales and Growth Rate (2015-2020)
Figure 48. North America Chagas Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Chagas Disease Drug Sales Market Share by Countries (2015-2020)
Figure 50. North America Chagas Disease Drug Sales Market Share by Countries in 2018
Figure 51. North America Chagas Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Chagas Disease Drug Revenue Market Share by Countries in 2018
Figure 53. United States Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Chagas Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Chagas Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Chagas Disease Drug Revenue Market Share by Countries in 2019
Figure 59. Germany Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Chagas Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Chagas Disease Drug Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Chagas Disease Drug Revenue Market Share by Regions 2019
Figure 67. China Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Chagas Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Chagas Disease Drug Sales Market Share by Countries in 2019
Figure 74. South America Chagas Disease Drug Revenue Market Share by Countries in 2019
Figure 75. Brazil Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Chagas Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Chagas Disease Drug Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Chagas Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Chagas Disease Drug Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Chagas Disease Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Chagas Disease Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Chagas Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Chagas Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Chagas Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Chagas Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Chagas Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Chagas Disease Drug Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
アルツハイマー病治療薬の世界市場 2020年 Market Overview The Alzheimer's Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- ベーチェット病治療薬の世界市場 2020年 Market Overview The global Behcet Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Behcet Disease Drug marke…
- シャルコー・マリー・トゥース病I型治療薬の世界市場 2020年 Market Overview The global Charcot-Marie-Tooth Disease Type I A Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cha…
- 疾患修飾性抗リウマチ治療薬の世界市場 2020年 Market Overview The global Disease-Modifying Antirheumatic Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Disease-…
- 鎌状赤血球症関連血管閉塞症の世界市場 2020年 Market Overview The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx mil…